| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.02 |